Sponsored Links

NanoViricides To Present Influenza Study Results At The TechConnect World 2011 Conference In Boston PDF Print E-mail
Events and Conferences - Conferences
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company") announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo. The Conferences and Expo are being held June 13-16 at the Hynes Convention Center in Boston, MA. Dr. Anil R...

Read more: Conferences News From Medical News Today